1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow IRCCS Multimedica: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Nintedanib for LymphAngioleioMyomatosis (LAM) Nintedanib - Lymphangioleiomyomatosis | Phase 2 | Completed | IRCCS Multimedica | 30 | 2016-12-06 | 2022-09-28 |
nintedanib (1)
Italy (1)